No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
APOA-II is the second most common protein in high-density lipoprotein (HDL).
Reduced serum levels apolipoprotein A2 and apolipoprotein C2 were significantly associated with the presence of aneurysm wall enhancement in MRI angiography.
Compared to CA19-9 alone, the combination of plasma CA19-9 and APOA2 isoforms ATQ/AT may improve detection of pancreatic cancer up to 18 months prior to diagnosis under usual care and may provide a useful first measure for pancreatic cancer detection prior to imaging.
cerulosplamin may be a marker of relapse and transferrin and apolipoprotein A-II may contribute to the evaluation of the treatment efficacy and avoiding a premature decision in Paracoccidioidomycosis.
Independent evidence indicated LpAI:A-II has a diameter 20% smaller than LpAI, consistent with a model having two apoA-I and one apoA-II
Weight loss resulted from a reduction of HDL in both APOE-II genotypes. However, in C homozygote carriers, it was shown that HDL3 reduced significantly and leads to a general shift toward larger size HDL subfractions after intervention, while in T allele carriers HDL2 decreased significantly and weight loss leads to shift toward smaller size HDL subfractions.
There was a statistically significant interaction between APOA2 polymorphism and dietary fatty acids intake on oxidative stress n patients with type 2 diabetes
This study detected a reduced level of heterodimer apoA2-ATQ/AT and a specific apoA2 isoform hypo-processing pattern in the sera of autoimmune pancreatitis patients.
apoA-II enhanced ABCA1-mediated cholesterol efflux
In type 2 diabetes mellitus patients, the dietary intake of antiinflammatory fatty acids, such as omega-3 PUFAs and MUFAs, could reduce the inflammatory effects associated with the Apolipoprotein A2 CC genotype. In addition, proinflammatory fatty acids, such as SFAs, could overcome the antiinflammatory effect of the T-allele.
data support an SR-B1 nibbling mechanism that is similar to that of streptococcal serum opacity factor, which also selectively removes CE and releases apoAI, leaving an apoAII-rich remnant.
A new missense mutation in an Iranian population has a significant association with high-density lipoprotein cholesterol levels.
ApoAII-ATQ/AT not only distinguished the early stages of pancreatic cancer from healthy controls but also identified patients at high risk for pancreatic malignancy.
ApoA1 and ApoA2 were independently associated with cognitive impairment.
Plasma apoB pool size of VLDL containing apoA-II is much smaller than that of VLDL without apoA-II, and this was caused by a very low rate of secretion of this VLDL type into plasma.
Clematichinenoside prevented dyslipidemia-induced atherosclerosis via hepatic PPARalpha/APOA1/APOA2/APOC3 metabolism.
APOA-II polymorphism and oxidative stress is associated with poor prognosis in patients with type 2 diabetes.
Apolipoprotein AII was detected as a protein associated with the urinary protein/urinary creatinine levels in pediatric idiopathic steroid-sensitive nephrotic syndrome
Apolipoprotein A-II/B significantly improves risk prediction of overall survival, also in carotid surgery patients with lower LDL levels
Apolipoprotein A-II and the regulation of high density lipoproteins in cardiovascular disease. [Review]
High Apolipoprotein A-II is associated with acute-phase response and AA amyloidosis by conformational changes of plasma lipoprotein structure.
Study reports a deterministic role for the B6 apoa2 gene polymorphism in respiratory rhythmogenesis. The in vivo inheritance pattern discloses a recessive effect of the B6 allele on the apnea phenotype, as the presence of both B6 alleles in the brain is required for transcript and trait expression; in contrast, apoa2 mRNA expression in the liver requires only one allele.
The C-terminal APOA2F peptide might inhibit further extension of amyloid fibrils by blocking the active ends of nuclei.
Data show that reticulum (ER) stress responses differed among tissues with extracellular AApoAII amyloid fibril deposition.
In vivo, neither C57 nor FVB apoA-II protein levels are affected by the absence of apoE, while an apoE/apoA-I double deficiency results in a 50% decrease of plasma FVB apoA-II but results in undetectable levels of C57 apoA-II in the plasma.
ApoA-I deficiency in mice is associated with redistribution of apoA-II and aggravated AApoAII amyloidosis.
Exacerbated hepatitis is observed in ApoA-II-deficient mice, indicating that ApoA-II plays a suppressive role in concanavalin A-induced hepatitis under physiological conditions.
Severe AApoAII deposits in the spleen, heart, skin, liver, and stomach were shown in the fish oil group compared with those in the butter and safflower oil groups (fish oil > butter > safflower oil group)
Apoa2 injected into mice induced amyloidosis.
tissue distribution, biochemical properties, and transmission of mouse type A AApoAII amyloid fibrils
the presence of apoA-II on HDL particles inhibits the ability of endothelial lipase to influence the metabolism of HDL in vivo
These studies indicate that increased levels of APOA2 protein lead to earlier and greater amyloid deposition and enhanced sensitivity to the transmission of amyloid fibrils in transgenic mice.
ApoAII is efficiently reabsorbed in kidney proximal tubules in relation to its plasma concentration
apoAII regulates the metabolism of triglyceride-rich lipoproteins, with HDL serving as a plasma reservoir of apoAII that is transferred to the triglyceride-rich lipoproteins in the same way as VLDL and chylomicrons acquire most of their apoCs from HDL
These results are compatible with a role for apolipoproteins in lipid metabolism and transport in the developing lung in association with the sex difference in surfactant lipid synthesis.
To understand the mechanism of amyloid fibril formation by apoA-II, we examined the polymerization of synthetic partial peptides of apoA-II in vitro.
The bovine APOA2 gene may be a strong candidate gene for body traits in the cattle breeding program.
The expression of ApoA-I and ApoA-II mRNA in the reproductive tract and their antibacterial properties against Escherichia coli suggest that seminal apolipoproteins play an important role in innate immunity in the rainbow trout reproductive tract.
The APOA2:c.131T>A polymorphism was associated with the fatty acid composition of backfat.
This gene encodes apolipoprotein (apo-) A-II, which is the second most abundant protein of the high density lipoprotein particles. The protein is found in plasma as a monomer, homodimer, or heterodimer with apolipoprotein D. Defects in this gene may result in apolipoprotein A-II deficiency or hypercholesterolemia.
, antimicrobial peptide BAMP-1
, apolipoprotein A-II
, Apolipoprotein A2
, uncharacterized protein LOC322327